A share price of Solid Biosciences Inc [SLDB] is currently trading at $4.37, up 4.55%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SLDB shares have gain 8.44% over the last week, with a monthly amount drifted -25.43%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Solid Biosciences Inc [NASDAQ: SLDB] stock has seen the most recent analyst activity on December 13, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $16. Previously, JMP Securities started tracking the stock with Mkt Outperform rating on December 10, 2024, and set its price target to $15. On July 15, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $15 on the stock. Leerink Partners upgraded its rating to a Outperform but stick to its price target of $12 on June 24, 2024. William Blair started tracking with a Outperform rating for this stock on March 28, 2024, and assigned it a price target of $40. In a note dated March 15, 2024, Citigroup initiated an Buy rating and provided a target price of $16 on this stock.
Solid Biosciences Inc experienced fluctuations in its stock price throughout the past year between $3.90 and $15.05. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. Solid Biosciences Inc [NASDAQ: SLDB] shares were valued at $4.37 at the most recent close of the market. An investor can expect a potential return of 300.46% based on the average SLDB price forecast.
Analyzing the SLDB fundamentals
Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at -23.67%, Pretax Profit Margin comes in at -21.63%, and Net Profit Margin reading is -21.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.59 and Total Capital is -0.59.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.15 points at the first support level, and at 3.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.48, and for the 2nd resistance point, it is at 4.59.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Solid Biosciences Inc [NASDAQ:SLDB] is 7.85. As well, the Quick Ratio is 7.85, while the Cash Ratio is 2.82.
Transactions by insiders
Recent insider trading involved Hanrahan Jessie, Chief Regulatory Officer, that happened on Dec 03 ’24 when 4610.0 shares were sold. Officer, Howton David T completed a deal on Dec 03 ’24 to buy 5072.0 shares. Meanwhile, President and CEO Cumbo Alexander sold 11114.0 shares on Dec 03 ’24.
